| Rus | Eng |
Electrochemical measurements can distinguish between different types of energy storage materials and their underlying mechanisms.
Batteries keep our devices working throughout the day — that is, they have a high energy density—but they can take hours to recharge when they run down. For rapid power delivery and recharging (i.e., high power density), electrochemical capacitors known as supercapacitors are used. One such application is regenerative braking, used to recover power in cars and electric mass transit vehicles that would otherwise lose braking energy as heat. However, supercapacitors have low energy density. Batteries and supercapacitors both rely on electrochemical processes, although separate electrochemical mechanisms determine their relative energy and power density.
During the past 5 to 7 years, the energy storage field has witnessed a dramatic expansion in research directed at materials that might combine the high energy density of batteries with the long cycle life and short charging times of supercapacitors. However, the blurring of these two electrochemical approaches can cause confusion and may lead to unwarranted claims unless careful attention is paid to fun-damental performance characteristics.
The prospect of developing materials with the energy density of batteries and the power density and cycle life of supercapacitors is an exciting direction that has yet to be realized. Whether to approach these goals by increasing the power density of battery materials or increasing the energy density of supercapacitors is one of the enticing features of the field. However, there needs to be clarity in the terminology used in combination with appropriate measurements and analyses. Proper evalua-tion of new materials and their charge storage mechanisms will facilitate progress in this important field of electrical energy storage.
Patrice Simon,Yury Gogotsi, Bruce Dunn "Where Do Batteries End and Supercapacitors Begin?"
SCIENCE 343, 1210 (2014); DOI: 10.1126/science.1249625
Source: www.sciencemag.org

MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
